Stereochemistry Basics: Chirality, Optical Activity, and 3D Molecular Shape
Chirality: Molecular Handedness
A molecule is chiral if it cannot be superimposed on its mirror image. The most familiar analogy is your hands: your left and right hands are mirror images but you cannot place one directly on top of the other so that all fingers align. A molecule is achiral if it can be superimposed on its mirror image, meaning it is identical to its reflection.
The most common cause of chirality in organic molecules is a tetrahedral carbon atom bonded to four different groups. This carbon is called a stereocenter, chiral center, or asymmetric carbon. For example, in 2-bromobutane (CH3CHBrCH2CH3), carbon 2 is bonded to a hydrogen, a bromine, a methyl group, and an ethyl group, four different substituents. This makes carbon 2 a stereocenter, and 2-bromobutane exists as two enantiomers.
Not all molecules with stereocenters are chiral. Meso compounds have two or more stereocenters but possess an internal plane of symmetry that makes the molecule achiral overall. Meso-tartaric acid (2R,3S-tartaric acid) has two stereocenters but is optically inactive because its two halves are mirror images of each other, and their effects cancel.
Chirality can also arise from other structural features: molecules with a chiral axis (like certain allenes and biphenyls), chiral planes (like certain cyclophanes), or helical chirality (like helicenes). However, the tetrahedral stereocenter is by far the most common source of chirality encountered in organic chemistry courses and in nature.
Assigning R and S Configuration
The Cahn-Ingold-Prelog (CIP) priority rules provide a systematic method for designating the absolute configuration of a stereocenter. First, assign priorities to the four substituents based on atomic number: the atom directly bonded to the stereocenter with the highest atomic number gets highest priority (priority 1), and so on down to the lowest (priority 4).
If two substituents start with the same atom, move outward along each chain until a point of difference is found. For example, an ethyl group (CH2CH3) outranks a methyl group (CH3) because at the first point of comparison both have carbon, but the ethyl group has a carbon at the next position while methyl has only hydrogens. Double and triple bonds are treated as if each bond were two or three separate single bonds to duplicate atoms.
Once priorities are assigned, orient the molecule so that priority 4 (lowest) points away from you. Then trace a path from priority 1 to 2 to 3. If this path is clockwise, the stereocenter has R configuration. If counterclockwise, it has S configuration. Every stereocenter in a molecule receives its own R or S designation independently.
Optical Activity and Polarimetry
When plane-polarized light passes through a solution of a chiral compound, the plane of polarization rotates. This phenomenon is called optical activity, and it is measured using a polarimeter. The measured rotation depends on the concentration of the sample, the path length of the cell, the wavelength of light used, the solvent, and the temperature.
The specific rotation is the standardized measure of optical activity. It is calculated as the observed rotation divided by the product of the path length (in decimeters) and the concentration (in grams per milliliter). A positive specific rotation (clockwise, designated (+) or d) does not correlate with R configuration, and a negative rotation (counterclockwise, (-) or l) does not correlate with S. The relationship between absolute configuration (R/S) and direction of rotation (+/-) must be determined experimentally for each compound.
A racemic mixture, containing equal amounts of both enantiomers, shows zero net optical rotation because the rotations of the two enantiomers exactly cancel. The enantiomeric excess (ee) measures how much one enantiomer predominates: 100% ee means a pure single enantiomer, 0% ee means a racemic mixture. A sample with 80% of one enantiomer and 20% of the other has 60% ee.
Stereochemistry and Biological Activity
The biological world is overwhelmingly homochiral. Proteins are built from L-amino acids (S configuration at the alpha carbon, with the exception of cysteine). Nucleic acids contain D-sugars (R configuration at several stereocenters). Enzymes, being chiral, distinguish between enantiomers of their substrates with exquisite precision. An enzyme that processes L-alanine typically has no activity toward D-alanine.
This chiral selectivity has critical implications for drug design. When a drug molecule is chiral, one enantiomer (the eutomer) typically provides the desired therapeutic effect, while the other (the distomer) may be inactive, less active, or actively harmful. Regulatory agencies increasingly require pharmaceutical companies to develop single-enantiomer drugs rather than racemic mixtures, or to thoroughly characterize the pharmacology of both enantiomers.
The most cited example is thalidomide: the R enantiomer was an effective sedative, while the S enantiomer caused severe birth defects. However, thalidomide is a complex case because the two enantiomers interconvert in the body. More straightforward examples include naproxen (the S enantiomer is anti-inflammatory; the R enantiomer causes liver damage) and ethambutol (the S,S enantiomer treats tuberculosis; the R,R enantiomer causes blindness).
Stereochemistry in Reactions
Many organic reactions create or destroy stereocenters, and the stereochemical outcome is often predictable from the mechanism. SN2 reactions proceed with inversion of configuration at the stereocenter (Walden inversion) because the nucleophile attacks from the opposite side of the leaving group. SN1 reactions proceed through a planar carbocation intermediate, leading to racemization because the nucleophile can attack from either face.
Addition to alkenes can be syn (both groups add to the same face, as in catalytic hydrogenation) or anti (groups add to opposite faces, as in bromination). These stereochemical outcomes produce specific diastereomeric products and are essential considerations in synthesis planning.
Asymmetric synthesis, the selective formation of one enantiomer over the other, is a major goal of modern organic chemistry. Chiral catalysts, chiral auxiliaries, and enzyme-catalyzed reactions can achieve high enantioselectivity, producing the desired enantiomer with greater than 99% ee in many cases. The development of asymmetric catalysis earned Knowles, Noyori, and Sharpless the Nobel Prize in Chemistry in 2001.
Stereochemistry governs how molecules exist in three-dimensional space. Chirality arises primarily from tetrahedral carbons with four different substituents, producing enantiomers that are mirror images with identical physical properties but different interactions with polarized light and with other chiral molecules. In biology and medicine, the correct stereochemistry is often the difference between a drug and a poison.